International Development and Education Award (IDEA)
The International Development and Education Award (IDEA) provides support for early-career oncologists in low- and middle-income countries by establishing strong relationships with leading ASCO members who serve as scientific mentors to each recipient. Recipients of this award will attend ASCO’s 2013 Annual Meeting (May 31 - June 4, 2013) and participate in a post-Meeting visit to their mentor’s institution in the U.S. or Canada. Recipients of this international award will also receive 3 years of complimentary ASCO membership, including a subscription to the Journal of Clinical Oncology.
On average, each IDEA alumnus shares the information and new skills they learned with 50 colleagues in his/her country. Watch this video to learn more about the IDEA program.
International Development and Education Award in Palliative Care (IDEA-PC)
The International Development & Education Award in Palliative Care (IDEA-PC) award is designed to provide support to oncologists who are interested in palliative medicine. The requirements and benefits of this international award are similar to those of the IDEA program, except that participants in the IDEA-PC program will be matched with ASCO mentors who specialize in palliative care, and eligible candidates must have a demonstrated interest in integrating palliative and supportive care services in their current institution.
Following is additional information for each IDEA award. Please be sure to download the materials that are specific to the award you are applying for. The Application Templates are not interchangeable.
|IDEA||IDEA in Palliative Care|
|Additional Information:||Request for Applications|
|Key Dates:||Applications for the 2013 IDEA are now closed.||Applications for the 2013 IDEA-PC are now closed.|
|Application Templates:||Applicant Information||Applicant Information|
|Letter of Recommendation||Letter of Recommendation|
|Institutional Approval||Institutional Approval|
The 2013 IDEAs are supported by:
|National Cancer Institute|
|Avon Foundation for Women||Open Society Foundations|
|Millennium: The Takeda Oncology Company||Teva Oncology|